Thoratec (NASDAQ: THOR) stock was pressured early on Friday after a NEJM study. While the study was concerning, it is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE